Virtual Multiple Myeloma Community Workshop
A virtual multiple myeloma workshop addressing the needs specific to communities in the Midwest region.
The IMF Virtual Regional Community Workshop will include an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on clinical trials. A member of the IMF Nurse Leadership Board will talk about managing side effects and symptoms of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions.
Welcome and Announcements
Kelly Cox, Senior Director IMF Regional Community Workshops
Myeloma 101 and Frontline Therapy
Rafat Abonour, MD (Indiana University) reviews multiple myeloma basics including what myeloma is, common symptoms and side effects, advances in how myeloma is initially diagnosed, the stages of myeloma treatment, induction therapy, transplant, and more.
Relapsed Therapy and Clinical Trials
Jonathan Kaufman, MD (Winship Cancer Institute - Emory University) discusses the types of relapsed disease, what doctors consider when selecting a treatment regimen, relapsed/refractory treatment options, how doctors treat triple and penta-class refractory myeloma, updates on clinical trials, and more.
Life is a Canvas, You are the Artist
Daniel Verina, DNP, ACNP-BC (IMF Nurse Leadership Board) discusses how patients can manage myeloma-related symptoms and side effects along with side effects brought on by treatment. She outlines the most common side effects for each myeloma drug category, how to prevent infection, and more.
Additional Resources:
Download the IMF's Multiple Myeloma Informational Booklets:
Download IMF publications
Workshop Sponsors:
With Support From: Abbvie, Amgen, Bristol Myers Squibb, Janssen, Karyopharm, Sanofi, and Takeda Oncology
(The IMF is not responsible for content provided by the links below and you may be subject to the Privacy Policy and Terms & Conditions of the destination site(s).)
 |
|
 |
Even the Odds |
 |
Revlimid Treatment Overview brochure |
 |
DARZALEX FASPRO® | DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) |
 |
Learn About Our Mechanism of Action KaryForward, Patient Support Program
|
 |
|
 |
